Clinical Trials Browser

Fanconi Anemia, Complementation Group D1, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04425200 2021-12-07

ZENSHIN

Completed

205 enrolled

Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT00858078 2021-11-30

A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women

Completed

76 enrolled

Classical hematology

Fanconi Anemia, Complementation Group D1

NCT00438906 2021-06-18

CAPS 3

Completed

200 enrolled

Classical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT03889171 2019-03-28

PSICOM

Completed

200 enrolled

BreastClassical hematologyGastrointestinalGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Withdrawn

BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Completed

176 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00509509 2012-05-24

High Risk Breast Cancer Screening Program

Unknown

BreastClassical hematology

Breast Cancer, Familial, Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00155896 2005-09-12

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

Unknown

100 enrolled

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Clinical Trials

C-PATROL

ZENSHIN

A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women

CAPS 3

PSICOM

Clinical Outcomes in Hereditary Cancer

Lynne Cohen Consortium Project: Multi-Center Database/Registry

High Risk Breast Cancer Screening Program

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer